서론 대상및방법 대상환자 스텐트시술방법 관동맥조영술상분석 추적검사및정의 997

Similar documents
Original Articles Korean Circulation J 1998;28 6 : 항혈소판요법을이용한관동맥내 Stent 삽입술의조기결과 손지원 김영준 손민수 오세진 안태훈 최인석 신익균 Initial Results after Implantation

황지웅

A 617

012임수진

Original Articles Korean Circulation J 2000;30 8 : 경요골동맥중재술에서심좌법의유용성에관한연구 최해종 김무현 양창호 차광수 김혜진김성근 이수훈 김상곤 김영대 김종성 Usefulness of Deep Seating Tec

untitled

Lumbar spine

hwp

Treatment and Role of Hormaonal Replaement Therapy

노영남

한국성인에서초기황반변성질환과 연관된위험요인연구

서론 대상및방법 대상환자 관상동맥조영술소견 551

저작자표시 - 비영리 - 변경금지 2.0 대한민국 이용자는아래의조건을따르는경우에한하여자유롭게 이저작물을복제, 배포, 전송, 전시, 공연및방송할수있습니다. 다음과같은조건을따라야합니다 : 저작자표시. 귀하는원저작자를표시하여야합니다. 비영리. 귀하는이저작물을영리목적으로이용할


< D B4D9C3CAC1A120BCD2C7C1C6AEC4DCC5C3C6AEB7BBC1EEC0C720B3EBBEC8C0C720BDC3B7C2BAB8C1A4BFA120B4EBC7D120C0AFBFEBBCBA20C6F2B0A E687770>

Abstract Background : Most hospitalized children will experience physical pain as well as psychological distress. Painful procedure can increase anxie

(Microsoft PowerPoint - S13-3_\261\350\273\363\307\366 [\310\243\310\257 \270\360\265\345])

1..

00약제부봄호c03逞풚

김범수

stents, and the mean CSAs of stents among proximal, mid, and distal segments. But the mean CSA of neointimal hyperplasia at the mid segment was larger

590호(01-11)

달생산이 초산모 분만시간에 미치는 영향 Ⅰ. 서 론 Ⅱ. 연구대상 및 방법 達 은 23) 의 丹 溪 에 최초로 기 재된 처방으로, 에 복용하면 한 다하여 난산의 예방과 및, 등에 널리 활용되어 왔다. 達 은 이 毒 하고 는 甘 苦 하여 氣, 氣 寬,, 結 의 효능이 있

기관고유연구사업결과보고

패션 전문가 293명 대상 앙케트+전문기자단 선정 Fashionbiz CEO Managing Director Creative Director Independent Designer

Microsoft Word - 순2-7.doc


서론 34 2


Original Articles Micro-Ⅱ Stent 의초기결과 류종철 장양수 김건영 이승환 김종현 전동운 심원흠 조승연 Abstract 조홍근 Immediate Results of AVE Micro- Stent Jong Cheol Ryu, M.D

433대지05박창용

원위부요척골관절질환에서의초음파 유도하스테로이드주사치료의효과 - 후향적 1 년경과관찰연구 - 연세대학교대학원 의학과 남상현

페링야간뇨소책자-내지-16

( )Jkstro011.hwp

54 한국교육문제연구제 27 권 2 호, I. 1.,,,,,,, (, 1998). 14.2% 16.2% (, ), OECD (, ) % (, )., 2, 3. 3

Trd022.hwp

Àå¾Ö¿Í°í¿ë ³»Áö

서론 대상 대상및방법 방법 1821

Pharmacotherapeutics Application of New Pathogenesis on the Drug Treatment of Diabetes Young Seol Kim, M.D. Department of Endocrinology Kyung Hee Univ


°ø±â¾Ð±â±â

03이경미(237~248)ok

....(....).hwp


[ 영어영문학 ] 제 55 권 4 호 (2010) ( ) ( ) ( ) 1) Kyuchul Yoon, Ji-Yeon Oh & Sang-Cheol Ahn. Teaching English prosody through English poems with clon

637

歯1.PDF

001-학회지소개(영)

서 론 관찰대상및방법 Fig. 1. Construction of the Crosswire TM distal tip. Table 1. Clinical characteristics and lesion characteristics Characteristics Age year

Minimally invasive parathyroidectomy

Â÷¼øÁÖ


서 론 대상 및 방법 대 상 706 Table 1. Characteristics of patients Number n 125 Age meansd 3514 Sex MF 7154 QRS duration sec Site of AP n Anterior 21 1

±èÇ¥³â

(Exposure) Exposure (Exposure Assesment) EMF Unknown to mechanism Health Effect (Effect) Unknown to mechanism Behavior pattern (Micro- Environment) Re

KIM Sook Young : Lee Jungsook, a Korean Independence Activist and a Nurse during the 이며 나름 의식이 깨어있던 지식인들이라 할 수 있을 것이다. 교육을 받은 간 호부들은 환자를 돌보는 그들의 직업적 소

12이문규

DBPIA-NURIMEDIA

충북의대학술지 Chungbuk Med. J. Vol. 27. No. 1. 1~ Charcot-Marie-Tooth Disease 환자의마취 : 증례보고 신일동 1, 이진희 1, 박상희 1,2 * 책임저자 : 박상희, 충북청주시서원구충대로 1 번지, 충북대학교

of medication with calcium channel blocker or nitrate compared with those in previous studies. Korean Circulation J 1999;293: KEY WORDSVariant

975_983 특집-한규철, 정원호

心臟疾病細胞治療之臨床試驗簡介

Kbcs002.hwp

½ÉÀå°úÇ÷°ü48È£_9


전립선암발생률추정과관련요인분석 : The Korean Cancer Prevention Study-II (KCPS-II)

- - 대상및방법 대상 방법 Korean Circulation J 2002;328:

<31342EBCBAC7FDBFB52E687770>

Vol.259 C O N T E N T S M O N T H L Y P U B L I C F I N A N C E F O R U M

untitled

<303820BFF8C0FA D BFC0B0E6BCF62DC1A4B8EDC8A32E687770>

Risk of Developing Hypertension by Daily Intake of Alcohol

歯14.양돈규.hwp

노인정신의학회보14-1호

DBPIA-NURIMEDIA

자기공명영상장치(MRI) 자장세기에 따른 MRI 품질관리 영상검사의 개별항목점수 실태조사 A B Fig. 1. High-contrast spatial resolution in phantom test. A. Slice 1 with three sets of hole arr

388 The Korean Journal of Hepatology : Vol. 6. No COMMENT 1. (dysplastic nodule) (adenomatous hyperplasia, AH), (macroregenerative nodule, MR

부속

<342EBEC8BCBABFAD2CB9DAC7E2C1D82E687770>


May 10~ Hotel Inter-Burgo Exco, Daegu Plenary lectures From metabolic syndrome to diabetes Meta-inflammation responsible for the progression fr

<30382EC0C7C7D0B0ADC1C22E687770>

Kor. J. Aesthet. Cosmetol., 및 자아존중감과 스트레스와도 밀접한 관계가 있고, 만족 정도 에 따라 전반적인 생활에도 영향을 미치므로 신체는 갈수록 개 인적, 사회적 차원에서 중요해지고 있다(안희진, 2010). 따라서 외모만족도는 개인의 신체는 타

878 Yu Kim, Dongjae Kim 지막 용량수준까지도 멈춤 규칙이 만족되지 않아 시행이 종료되지 않는 경우에는 MTD의 추정이 불가 능하다는 단점이 있다. 최근 이 SM방법의 단점을 보완하기 위해 O Quigley 등 (1990)이 제안한 CRM(Continu

44-4대지.07이영희532~

歯제7권1호(최종편집).PDF

(

Microsoft Word - 순8-5.doc

139~144 ¿À°ø¾àħ

歯 PDF

ºÎÁ¤¸ÆV10N³»Áö

15(2)-7.fm

a16.PDF


( ) ) ( )3) ( ) ( ) ( ) 4) 1915 ( ) ( ) ) 3) 4) 285

저작자표시 - 비영리 - 동일조건변경허락 2.0 대한민국 이용자는아래의조건을따르는경우에한하여자유롭게 이저작물을복제, 배포, 전송, 전시, 공연및방송할수있습니다. 이차적저작물을작성할수있습니다. 다음과같은조건을따라야합니다 : 저작자표시. 귀하는원저작자를표시하여야합니다. 비


< C6AFC1FD28B1C7C7F5C1DF292E687770>

09È«¼®¿µ 5~152s

Á¦È¯ÁØ

Transcription:

Original Articles Korean Circulation J 2001;3110:996-1003 70 세이상고령환자의관동맥스텐트시술의특징 정욱성 김종진 승기배 조은주 문건웅 이종민 오용석윤호중 채장성 박인수 김재형 최규보 홍순조 Characteristics of Coronary Artery Stenting in the Elderly over 70 Years Old Short-Term Outcome and Long-Term Angiographic and Clinical Follow-up Wook Sung Chung, MD, Chong Jin Kim, MD, Ki Bae Seung, MD, Eun Joo Cho, MD, Keon Woong Moon, MD, Jong Min Lee, MD, Young Suk Oh, MD, Ho Joong Youn, MD, Jang Seong Chae, MD, Ihn Soo Park, MD, Jae Hyung Kim, MD, Kyu Bo Choi, MD and Soon Jo Hong, MD Department of Internal Medicine, Medical College, The Catholic University of Korea, Seoul, Korea ABSTRACT Background and ObjectivesThe average population in Korea is gradually becoming older. Elderly patients undergoing coronary revascularization are considered to be a high-risk group. There is a paucity of data that relates the results of stenting in treating coronary artery disease in the elderly population. This study compared the short- and long-term outcomes of elderly patients undergoing coronary artery stenting with those of younger patients. Materials and MethodThe elddrly patients 70 years of age who underwent coronary artery stenting between January 1997 and July 1999 n106 at our centers were compared with patients 70 years of age who also underwent coronary artery stenting during the same time period n597. ResultsElderly patients presented with a lower ejection fraction 52.9% vs. 57.4%, p0.001, more unstable angina 47% vs. 31%, p0.003, and a greater incidence of multivessel disease 67% vs. 51%, p0.005 than the younger patients. There were no differences in major in-hospital complications including death 0.9% vs. 0.5%, p NS, procedural acute Q-wave myocardial infarction 0.9% vs. 0.3%, pns, and emergency CABG 0% vs. 0.3%, pns between two groups. Furthermore, the vascular complication rate was similar between the two groups 1.9% vs. 1.0%, pns. An angiographic follow-up, obtained in both groups, demonstrated similar restenosis rates 26.5% vs. 24.9%, pns. Long-term clinical follow-up at 12 months showed that major adverse cardiac events including death, acute myocardial infarction, and repeat revascularization were significantly higher in elderly patients than in younger patients 18.3% vs. 12.6%, p0.04. ConclusionElderly patients with higher risk factors who underwent coronary artery stenting had similar rates of in-hospital procedural complications and similar rates of angiographic restenosis after 6 months follow-up, compared to younger patients. The overall rates of major adverse cardiac events in the elderly population at 12 months postcoronary artery stenting were significantly higher than those of younger patients. Korean Circulation J 2001; 3110:996-1003 KEY WORDSAgedStentsFollow-up studies. 996

서론 대상및방법 대상환자 스텐트시술방법 관동맥조영술상분석 추적검사및정의 997

통계분석 결과 대상환자의임상적특징 관동맥조영술소견과스텐트시술에관련된특징 Table 1. Clinical characteristics of 703 patients Age70 n106 Age70 n597 Mean age years 74 4 56 8 Male, n % 54 51 437 73 0.001 Risk factors, n % Hypercholesterolemia 220 mg/dl 24 23 143 24 NS Hypertension 48 45 263 44 NS Current smoker 28 26 233 39 0.006 Diabetes 15 14 148 25 0.008 Renal insufficiency creatinine2.0 mg/dl, n % 8 7.5 22 3.7 0.04 LVEF % 52.911.9 57.413.1 0.001 Prior myocardial infarction, n % 16 15 72 12 NS Clinical diagnosis, n % Stable angina 42 40 340 57 0.004 Unstable angina 50 47 185 31 0.003 Acute myocardial infarction 14 13 72 12 NS Number of diseased vessels, n % 1 35 33 293 49 0.003 2 34 32 185 31 NS 3 37 35 119 20 0.005 Multivessel disease, n % 71 67 304 51 0.005 NSnot significant, LVEFleft ventricular ejection fraction p 998 Korean Circulation J 2001;3110:996-1003

Table 2. Angiographic and procedural characteristics of 819 lesions Artery stented, n % Age70 n134 Age70 n685 p Left main 2 1.5 10 1.5 NS Left anterior descending 74 55.1 369 53.8 NS Left circumflex 25 18.9 117 17.1 NS Right coronary artery 33 24.5 187 27.3 NS Saphenous vein graft 0 2 0.3 NS Modified AHA/ACC lesion type, n % A 12 9 68 10 NS B1 36 27 233 34 0.02 B2 67 50 295 43 0.03 C 19 14 89 13 NS B2 or C 86 64 384 56 0.02 Total occlusion, n % 12 9 89 13 NS Mean reference diameter mm 2.90 0.66 3.09 1.17 NS Lesion % stenosis 81.1 17.3 81.3 16.8 NS Final stent MLD mm 2.87 0.75 3.06 1.17 NS Lesion length mm 10.9 6.0 11.3 6.1 NS Maximal inflation pressure atm 12.9 6.0 13.3 6.1 NS Number of stent per patient 1.26 0.51 1.15 0.39 0.04 Use of IABP, n % 2 1.9 8 1.3 NS AHA/ACCAmerican heart association/american college of cardiology, MLDminimal luminal diameter, IABPintraaortic balloon counterpulsation, NSnot significant Table 3. In-hospital clinical data Age70 n106 Age70 n597 p All major cardiac event 2 1.8 7 1.2 NS Death 1 0.9 3 0.5 NS Q-wave myocardial infarction 1 0.9 2 0.3 NS Emergency CABG 0 2 0.3 NS Non-Q wave myocardial infarction 10 9.4 31 5.2 0.01 Vascular complication 2 1.9 6 1.0 NS CABGcoronary artery bypass graft surgery, NSnot significant 병원내주요임상사건의비교 추적관동맥조영술소견 999

Table 4. Angiographic data at follow-up Age70 n131 Age70 n681 p Follow-up % 83 63 469 69 Follow-up duration days 224113 206114 Mean reference diameter mm 2.940.59 3.09 1.17 NS Stent MLD mm 1.801.14 1.88 1.03 NS Stent % stenosis 38.7 9.0 39.1 11.7 NS Angiographic restenosis rate % 26.5 24.9 NS Type of restenosis % Focal 9 45 54 46 NS Diffuse 8 37 39 33 NS Proliferative 4 18 24 21 NS MLDminimal luminal diameter, NSnot significant Table 5. Clinical data at follow-up Age70 n104 Age70 n594 p Follow-up % 97 93 558 94 Follow-up duration days 357265 376270 MACE % 19 18.3 75 12.6 0.04 Cardiac death 2 1.9 2 0.5 NS Acute myocardial infarction 2 1.9 3 0.5 NS Revascularization 15 14.4 70 11.8 NS PCI 14 13.5 68 11.4 NS CABG 1 1.0 2 0.5 NS MACEmajor adverse cardiac event, PCIpercutaneous coronary intervention, CABGcoronary artery bypass graft surgery, NSnot significant 장기주요임상사건의비교 고찰 1000 Korean Circulation J 2001;3110:996-1003

요약 배경및목적 : 1001

방법 : 결과 : 결론 : 1002 중심단어 REFERENCES 1) Peterson ED, Jollis JG, Bebchuck JD, DeLong ER, Muhlbaier LH, Mark DB, Pryor DB. Changes in mortality after myocardial revascularization in the elderly. Ann Intern Med 1994121919-27. 2) Little T, Milner MR, Lee K, Constantine J, Pichard AD, Lindsay J Jr. Late outcome and quality of life following percutaneous transluminal coronary angioplasty in octogenarians. Cathet Cardiovasc Diagn 199329261-6. 3) O Keefe JH, Sutton MB, McCallister BD, Vacek JL, Piehler JM, Ligon RW, Hartzler GC. Coronary angioplasty versus bypass surgery in patients 70 years old matched for ventricular function. J Am Coll Cardiol 199424425-30. 4) Morrison DA, Bies RD, Sacks J. Coronary angioplasty for elderly patients with high risk unstable angina shortterm outcomes and long-term survival. J Am Coll Cardiol 199729339-44. 5) Thompson RC, Holmes DR, Grill DE, Mock MB, Bailey KR. Changing outcome of angioplasty in the elderly. J Am Coll Cardiol 1996278-14. 6) Santana JO, Haft JI, LaMarche NS, Goldstein JE. Coronary angioplasty in patients eighty years of age or older. Am Heart J 199212413-8. 7) Thompson RC, Holmes DR, Gersh BJ, Mock MB, Bailey KR. Percutaneous transluminal coronary angioplasty in the elderly early and long term results. J Am Coll Cardiol 1991171245-50. 8) Lindsay J, Reddy VM, Pinnow EE, Little T, Pichard AD. Morbidity and mortality rates in elderly patients undergoing percutaneous coronary transluminal angioplasty. Am Heart J 1994128697-702. 9) Tan KH, Sulke N, Taub N, Karani S, Sowton E. Percutaneous transluminal coronary angioplasty in patients 70 years of age or older 12 years experience. Br Heart J 199574310-7. 10) Roach GW, Kanchuger M, Mangano CM, Newman M, Nussmeier N, Wolman R, Aggarwal A, Marschall K, Graham SH, Ley C. Adverse cerebral outcomes after coronary bypass surgery. N Engl J Med 19963351857-63. 11) Hannan EL, Burke J. Effect of age on mortality in coronary artery bypass surgery in New York, 19911992. Am Heart J 19941281184-91. 12) Fishman RF, Kuntz RE, Carozza JP, Friedrich SP, Gordon PC, Senerchia CC, Baim DS. Acute and long term results of coronary stents and atherectomy in women and the elderly. Coron Artery Dis 19956159-68. 13) Ten Berg JM, Voors AA, Suttorp MJ, Ernst SM, Mast EG, Bal E, Plokker HW. Long term results after successful percutaneous transluminal coronary angioplasty in patients over 75 years of age. Am J Cardiol 199677690-5. 14) Paul SD, O Gara PT, Mahjoub ZA, DiSalvo TG, O Do- Korean Circulation J 2001;3110:996-1003

nnell CJ, Newell JB, Villarreal-Levy G, Smith AJ, Kondo NI, Cararach M, Ferrer L, Eagle KA. Geriatric patients with acute myocardial infarction Cardiac risk factor profiles, presentation, thrombolysis, coronary interventions and prognosis. Am Heart J 1996131710-5. 15) Maiello L, Colombo A, Gianrossi R, Thomas J, Finci L. Results of coronary angioplasty in patients aged 75 years and older. Chest 1992102375-9. 16) Elliot JM, MacIsaac AI, Lefkovits J, Horrigan MC, Franco I, Whitlow PL. New coronary devices in the elderly comparison with angioplasty. Circulation 199490suppl II-333. 17) Schomig A, Neumann FJ, Kastrati A, Schuhlen H, Blasini R, Hadamitzky M, Walter H, Zitzmann-Roth EM, Richardt G, Alt E, Schmitt C, Ulm K. A randomized comparison of antiplatelet and anticoagulation therapy after the placement of coronary artery stents. N Engl J Med 19963341084-9. 18) Colombo A, Hall P, Nakamura S, Almagor Y, Maiello L, Martini G, Gaglione A, Goldberg SL, Tobis JM. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995 911676-88. 19) Moussa I, Di Mario C, Reimers B, Akiyama T, Tobis J, Colombo A. Subacute stent thrombosis in the era of intravascular ultrasound guided coronary stenting without anticoagulation frequency, predictors and clinical outcome. J Am Coll Cardiol 1997296-12. 20) Ryan TJ, Bauman WB, Kennedy JW, Kereiakes DJ, King III SB, McCallister BD, Smith SC, Ullyot DJ. Guidelines for percutaneous transluminal angioplasty a report of the American College of Cardiology/American Heart Association task force on assessment of diagnostic and therapeutic cardiovascular procedures. J Am Coll Cardiol 1993222033-54. 21) Reimers B, Moussa I, Akiyama T, Tucci G, Ferraro M, Martini G, Blengino S, Di Mario C, Colombo A. Longterm clinical follow-up after successful repeat percutaneous intervention for stent restenosis. J Am Coll Cardiol 199730186-92. 22) Yokoi H, Kimura T, Nakagawa Y, Nosaka H, Nobuyoshi M. Long-term clinical and quantitative angiographic follow-up after the Palmaz-Schatz stent restenosis. J Am Coll Cardiol 199627suppl A224A. 23) Carrozza JP, Kuntz RE, Levine MJ, Pomerantz RM, Fishman RF, Mansour M, Gibson CM, Senerchia CC, Diver DJ, Safian RD. Angiographic and clinical outcome of intracoronary stenting immediate and long-term results from a large singlecenter experience. J Am Coll Cardiol 199220328-37. 24) De Gregorio J, Kobayashi Y, Albiero R, Reimers B, Di Mario C, Finci L, Colombo A. Coronary artery stenting in the elderly short-term outcome and long-term angiographic and clinical follow-up. J Am Coll Cardiol 1998 32577-83. 25) Abizaid AS, Mintz GS, Abizaid A, Saucedo JF, Mehran R, Pichard AD, Kent KM, Satler LF, Leon MB. Influence of patient age on acute and late clinical outcomes following Palmaz-Schatz coronary stent implatation. Am J Cardiol 200085338-43. 1003